Bronchogen is a synthetic short-chain peptide bioregulator modeled after calf thymus and respiratory tissue extracts studied for cellular repair and gene expression. PX1 Research provides analytical-grade Bronchogen synthesized in USA-based, GMP-compliant facilities with batch-specific third-party laboratory verification for qualified academic and institutional investigators.
Bronchogen is a synthetic short-chain peptide bioregulator modeled after calf thymus and respiratory tissue extracts studied for cellular repair and gene expression. PX1 Research provides analytical-grade Bronchogen synthesized in USA-based, GMP-compliant facilities with batch-specific third-party laboratory verification for qualified academic and institutional investigators.
To buy Bronchogen calf thymus peptide for laboratory research, investigators must select suppliers providing verified purity credentials, including high-performance liquid chromatography (HPLC) and electrospray ionization mass spectrometry (ESI-MS) documentation. PX1 Research supplies USA-manufactured, analytical-grade Bronchogen featuring lot-specific Certificates of Analysis (COAs) and certified low-endotoxin thresholds for in vitro and preclinical experimentation.
When purchasing synthetic tissue-specific bioregulators like Bronchogen, researchers should ensure the compound has been validated for sequence accuracy, heavy metal absence, and structural integrity. All peptides distributed through our research peptide store undergo ISO 17025 accredited analytical testing prior to release, supporting reproducible research across pulmonary biology and cellular immunology assays.
Bronchogen is a synthetic tetrapeptide comprised of four specific amino acid residues (Ala-Glu-Asp-Leu). The molecular design of this sequence originated from structural characterization of biological peptide complexes isolated from bovine tissue, specifically calf thymus and bronchial mucosal tissues. Research pioneered by Khavinson and colleagues established that short oligopeptides derived from calf thymus hydrolysates exhibit selective site-specific interactions with genomic DNA.
While early bioregulator research relied on crude organ extracts from juvenile bovine calf thymus glands, modern peptide synthesis allows for exact sequence replication without animal-derived contamination risks. The Bronchogen research peptide synthesized by PX1 Research represents a 99%+ pure chemical compound identical to the biologically active tetrapeptide sequence, allowing precise quantitative dosing in cellular culture and animal tissue preparations without batch variance.
Preclinical studies indicate that short peptide bioregulators such as Bronchogen act primarily through epigenetic mechanisms rather than direct classical receptor binding. In vitro molecular assays demonstrate that short peptide sequences can penetrate the plasma membrane and nuclear envelope, interacting directly with specific nucleosome motifs and histone proteins.
In vitro data suggest that Bronchogen binds to promoter regions of genes regulating bronchial epithelial structural integrity, antioxidant enzyme expression, and cellular proliferation. By modulating local chromatin accessibility, the peptide is hypothesized to influence transcription factor binding, promoting tissue-specific protein synthesis in bronchial cell lines. Researchers investigating chromatin architecture often reference our molecular biology research portal for comparative datasets on peptide-DNA interactions.
Investigative studies utilizing rodent models of acute and chronic pulmonary inflammation have documented significant alterations in cytokine production following administration of synthetic calf thymus-derived peptides. In animal models subjected to environmental toxins or induced oxidative stress, treatment with Bronchogen was associated with decreased expression of pro-inflammatory markers such as TNF-alpha and IL-6 within bronchoalveolar lavage fluid.
Additionally, histological evaluations in animal research indicate that Bronchogen supplementation in experimental groups supported ciliated cell density and mucous membrane restoration across damaged tracheal and bronchial tissues. These observations highlight the compound's utility in research models evaluating chronic obstructive airway conditions, tissue remodeling, and epithelial barrier dysfunction.
Bronchogen belongs to a broader class of short synthetic peptide bioregulators derived from organ-specific transcriptomic research. To understand its distinct biochemical profile, investigators frequently compare Bronchogen against related thymic and respiratory peptides within identical laboratory protocols.
While Bronchogen specifically targets bronchial tissue signaling and pulmonary gene expression, the related peptide Thymogen (Glu-Trp) is primarily evaluated for broad-spectrum T-cell differentiation and systemic immune modulation. Similarly, Chonluten (Glu-Asp-Gly) serves as an alternative respiratory bioregulator targeting lung parenchyma and alveolar elasticity. In tissue repair models outside the pulmonary system, researchers often contrast these short signals with pleiotropic repair agents such as BPC-157 to evaluate differential pathways of cell migration and extracellular matrix stabilization.
Maintaining rigorous quality control is critical when purchasing peptides for sensitive cellular assays. Impurities, truncated synthesis products, or residual TFA (trifluoroacetic acid) can confound experimental outcomes in cell culture and animal studies. Every lot of Bronchogen offered by PX1 Research undergoes rigorous testing in an ISO 17025 accredited laboratory.
Our quality assurance protocol requires Reverse-Phase HPLC to confirm purity exceeding 98%, ESI-MS to confirm correct molecular weight, and chromogenic LAL assays to ensure endotoxin levels remain strictly under 0.1 EU/mg. Institutional buyers managing large-scale screening projects can review bulk lot documentation through our wholesale lab portal.
Bronchogen is supplied as a lyophilized (freeze-dried) powder to maximize chemical stability during transport and long-term storage. Upon receipt, lyophilized vials should be stored at -20°C in a desiccated environment protected from light exposure.
For laboratory reconstitution, researchers should utilize sterile bacteriostatic water or sterile 0.9% sodium chloride solution depending on experimental cellular toxicity thresholds. Gentle swirling of the vial is recommended; aggressive vortexing should be avoided to prevent peptide shear stress. Reconstituted solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles and maintained at 2°C to 8°C for short-term use.
PX1 Research is dedicated to supplying standard-setting laboratory reagents for academic institutions, biotechnology companies, and independent researchers across the United States. We maintain complete domestic oversight over synthesis, purification, and packaging operations.
All orders ship directly from our state-of-the-art dispatch centers located in California and Arizona, providing same-day shipping for orders placed before 3 PM PST Monday through Friday. With robust lot traceability and direct access to raw laboratory data, PX1 Research remains the preferred primary supplier for researchers seeking to buy Bronchogen calf thymus peptides.
What is Bronchogen peptide?
Bronchogen is a synthetic short-chain tetrapeptide (Ala-Glu-Asp-Leu) modeled after bioregulatory peptides originally isolated from bovine calf thymus and bronchial mucosal tissues. It is studied for its role in gene expression and respiratory tissue maintenance.
Is the Bronchogen sold by PX1 Research derived from actual calf thymus glands?
No. PX1 Research supplies 100% synthetically manufactured Bronchogen. This eliminates any risk of biological contamination or prionic materials while ensuring identical molecular structure and precise purity for laboratory research.
What is the primary research application for Bronchogen?
Bronchogen is utilized in preclinical research to investigate pulmonary epithelial gene regulation, inflammatory cytokine suppression in bronchial cell lines, tissue remodeling, and cellular repair mechanisms.
How is Bronchogen purity verified?
PX1 Research verifies every batch through an independent ISO 17025 accredited laboratory using Reverse-Phase HPLC to establish target purity (>98%) and Mass Spectrometry (ESI-MS) to verify precise molecular weight.
What are the endotoxin limits for PX1 Research Bronchogen?
All peptide lots undergo kinetic chromogenic LAL testing to verify endotoxin levels are under 0.1 EU/mg, ensuring suitability for sensitive cell culture and in vivo animal models.
How should lyophilized Bronchogen be stored upon arrival?
Lyophilized Bronchogen should be stored at -20°C in a dry, dark location. Under these conditions, the un-reconstituted peptide remains stable for up to 24 months.
Can Bronchogen be purchased for human clinical use or personal administration?
No. Bronchogen provided by PX1 Research is strictly designated for in vitro, cellular, and preclinical laboratory research. It is not approved for clinical, therapeutic, human, or veterinary use.
Where does PX1 Research ship Bronchogen from?
All products are fulfilled directly from our facility locations in California and Arizona, featuring same-day dispatch for qualified orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.